 <h1>Ceftibuten Side Effects</h1><ul class="ddc-anchor-links"><li>Consumer</li>
<li>Professional</li></ul><h2>In Summary</h2><p><b>More frequently reported side effects include:</b> nausea.  See below for a comprehensive list of adverse effects.</p><h2 class="ddc-anchor-offset" id="consumer">For the Consumer</h2><p><i>Applies to ceftibuten: oral powder for suspension</i></p><h3>Side effects requiring immediate medical attention</h3><p>Along with its needed effects, ceftibuten may cause some unwanted effects. Although not all of these side effects may occur, if they do occur they may need medical attention.</p><p>
<b>Check with your doctor immediately</b> if any of the following side effects occur while taking ceftibuten:</p><p>
<i>Rare</i>
</p><ul>
<li>Burning while urinating</li>
<li>confusion</li>
<li>decreased urination</li>
<li>difficult or labored breathing</li>
<li>difficult or painful urination</li>
<li>dizziness</li>
<li>dry mouth</li>
<li>fainting</li>
<li>fever</li>
<li>increase in heart rate</li>
<li>lightheadedness</li>
<li>rapid breathing</li>
<li>shortness of breath</li>
<li>sunken eyes</li>
<li>thirst</li>
<li>tightness in the chest</li>
<li>unusual tiredness or weakness</li>
<li>wheezing</li>
<li>wrinkled skin</li>
</ul><p>
<i>Incidence not known</i>
</p><ul>
<li>Abdominal or stomach cramps or tenderness</li>
<li>back, leg, or stomach pains</li>
<li>bleeding gums</li>
<li>blistering, peeling, or loosening of the skin</li>
<li>bloating</li>
<li>bloody or cloudy urine</li>
<li>bloody, black, or tarry stools</li>
<li>chest pain</li>
<li>chills</li>
<li>clay-colored stools</li>
<li>cloudy urine</li>
<li>cough or hoarseness</li>
<li>coughing up blood</li>
<li>dark urine</li>
<li>decrease in urine output or decrease in urine-concentrating ability</li>
<li>diarrhea</li>
<li>diarrhea, watery and severe, which may also be bloody</li>
<li>difficulty with breathing or swallowing</li>
<li>fast heartbeat</li>
<li>feeling of discomfort</li>
<li>feeling that others are watching you or controlling your behavior</li>
<li>feeling that others can hear your thoughts</li>
<li>feeling, seeing, or hearing things that are not there</li>
<li>fever with or without chills</li>
<li>general body swelling</li>
<li>general feeling of tiredness or weakness</li>
<li>high fever</li>
<li>hives</li>
<li>increased menstrual flow or vaginal bleeding</li>
<li>increased thirst</li>
<li>inflammation of the joints</li>
<li>itching</li>
<li>joint or muscle pain</li>
<li>loss of appetite</li>
<li>lower back or side pain</li>
<li>muscle aches</li>
<li>nausea or vomiting</li>
<li>noisy breathing</li>
<li>nosebleeds</li>
<li>pain</li>
<li>pale skin</li>
<li>paralysis</li>
<li>problems with speech or speaking</li>
<li>prolonged bleeding from cuts</li>
<li>puffiness or swelling of the eyelids or around the eyes, face, lips, or tongue</li>
<li>red or black, tarry stools</li>
<li>red or dark brown urine</li>
<li>red skin lesions, often with a purple center</li>
<li>red, irritated eyes</li>
<li>seizures</li>
<li>severe mood or mental changes</li>
<li>skin rash</li>
<li>sore throat</li>
<li>sores, ulcers, or white spots on the lips or in the mouth</li>
<li>sudden decrease in the amount of urine</li>
<li>swollen lymph glands</li>
<li>swollen or painful glands</li>
<li>unpleasant breath odor</li>
<li>unusual behavior</li>
<li>unusual bleeding or bruising</li>
<li>unusual weight loss</li>
<li>vomiting of blood</li>
<li>wheezing</li>
<li>yellowing of the eyes or skin </li>
</ul><h3>Side effects not requiring immediate medical attention</h3><p>Some side effects of ceftibuten may occur that usually <b>do not need medical attention</b>. These side effects may go away during treatment as your body adjusts to the medicine. Also, your health care professional may be able to tell you about ways to prevent or reduce some of these side effects.</p><p>Check with your health care professional if any of the following side effects <b>continue or are bothersome</b> or if you have any questions about them:</p><p>
<i>Less common</i>
</p><ul>
<li>Acid or sour stomach</li>
<li>belching</li>
<li>heartburn</li>
<li>indigestion</li>
<li>loose stools</li>
<li>stomach discomfort, upset, or pain</li>
</ul><p>
<i>Rare</i>
</p><ul>
<li>Agitation</li>
<li>bad, unusual, or unpleasant (after) taste</li>
<li>bloated, full feeling</li>
<li>burning, crawling, itching, numbness, prickling, "pins and needles", or tingling feelings</li>
<li>change in taste</li>
<li>constipation</li>
<li>cracks in the skin at the corners of the mouth</li>
<li>dry mouth</li>
<li>excess air or gas in the stomach or intestines</li>
<li>feeling unusually cold</li>
<li>full feeling</li>
<li>headache</li>
<li>hives or welts</li>
<li>increase in the body movements</li>
<li>irritability</li>
<li>itching of the vagina or genital area</li>
<li>pain during sexual intercourse</li>
<li>passing gas</li>
<li>redness of the skin</li>
<li>shivering</li>
<li>sleepiness or unusual drowsiness</li>
<li>sleeplessness</li>
<li>soreness or redness around the fingernails and toenails</li>
<li>stuffy nose</li>
<li>thick, white vaginal discharge with no odor or with a mild odor</li>
<li>trouble with sleeping</li>
<li>unable to sleep</li>
<li>weight loss</li>
</ul><p>
<!-- end oral powder for suspension --><div class="related-links"><svg aria-hidden="true" class="ddc-icon ddc-icon-info" focusable="false" height="22" viewbox="0 0 24 24" width="22" xmlns="http://www.w3.org/2000/svg"><path d="M14 2H6c-1.1 0-1.99.9-1.99 2L4 20c0 1.1.89 2 1.99 2H18c1.1 0 2-.9 2-2V8l-6-6zm2 16H8v-2h8v2zm0-4H8v-2h8v2zm-3-5V3.5L18.5 9H13z"></path></svg> <span>Managing side effects <span class="ddc-text-nowrap">(general information)</span></span></div>
<h2 class="ddc-anchor-offset" id="professional">For Healthcare Professionals</h2><p><i>Applies to ceftibuten: oral capsule, oral powder for reconstitution</i></p><h3>General</h3><p>This drug was generally well tolerated.  In clinical trials, 2% of patients discontinued medication due to adverse events, primarily diarrhea, nausea, or vomiting, and 0.3% discontinued due to rash or pruritus.<sup>[Ref]</sup></p><h3>Gastrointestinal</h3><p>The onset of pseudomembranous colitis symptoms has been reported during or after antibacterial therapy.<sup>[Ref]</sup></p><p><b>Common</b> (1% to 10%): Nausea, diarrhea, dyspepsia, abdominal pain, vomiting</p>
<p><b>Uncommon</b> (0.1% to 1%): Constipation, dry mouth, eructation, flatulence, loose stools</p>
<p><b>Postmarketing reports</b>: Melena</p>
<p></p>
<p>Cephalosporin-class:</p>
<p>-Frequency not reported: Pseudomembranous colitis<sup>[Ref]</sup></p><h3>Nervous system</h3><p>Some cephalosporins have been associated with seizures, especially in patients with renal dysfunction whose dose was not reduced.<sup>[Ref]</sup></p><p><b>Common</b> (1% to 10%): Headache, dizziness</p>
<p><b>Uncommon</b> (0.1% to 1%): Somnolence, taste perversion, paresthesia</p>
<p><b>Frequency not reported</b>: Hyperkinesia</p>
<p><b>Postmarketing reports</b>: Aphasia</p>
<p></p>
<p>Cephalosporin-class:</p>
<p>-Frequency not reported: Seizures<sup>[Ref]</sup></p><h3>Hepatic</h3><p><b>Common</b> (1% to 10%): Increased ALT, increased bilirubin</p>
<p><b>Uncommon</b> (0.1% to 1%): Increased AST</p>
<p><b>Postmarketing reports</b>: Jaundice</p>
<p></p>
<p>Cephalosporin-class:</p>
<p>-Frequency not reported: Hepatic cholestasis<sup>[Ref]</sup></p><h3>Hematologic</h3><p><b>Common</b> (1% to 10%): Increased eosinophils, decreased hemoglobin</p>
<p><b>Uncommon</b> (0.1% to 1%): Increased platelets, decreased platelets, decreased leukocytes</p>
<p></p>
<p>Cephalosporin-class:</p>
<p>-Frequency not reported: Aplastic anemia, hemolytic anemia, prolonged prothrombin time, hemorrhage, neutropenia, pancytopenia, agranulocytosis<sup>[Ref]</sup></p><h3>Renal</h3><p><b>Common</b> (1% to 10%): Increased BUN</p>
<p><b>Uncommon</b> (0.1% to 1%): Increased creatinine</p>
<p></p>
<p>Cephalosporin-class:</p>
<p>-Frequency not reported: Renal dysfunction, toxic nephropathy<sup>[Ref]</sup></p><h3>Dermatologic</h3><p><b>Uncommon</b> (0.1% to 1%): Pruritus, rash, urticaria</p>
<p><b>Frequency not reported</b>: Diaper dermatitis</p>
<p><b>Postmarketing reports</b>: Stevens-Johnson syndrome, toxic epidermal necrolysis</p>
<p></p>
<p>Cephalosporin-class:</p>
<p>-Frequency not reported: Stevens-Johnson syndrome, erythema multiforme<sup>[Ref]</sup></p><h3>Other</h3><p><b>Uncommon</b> (0.1% to 1%): Fatigue, moniliasis, increased alkaline phosphatase</p>
<p><b>Frequency not reported</b>: Fever, rigors, transient increases in lactate dehydrogenase</p>
<p></p>
<p>Cephalosporin-class:</p>
<p>-Frequency not reported: Drug fever<sup>[Ref]</sup></p><h3>Metabolic</h3><p><b>Uncommon</b> (0.1% to 1%): Anorexia</p>
<p><b>Frequency not reported</b>: Dehydration</p>
<p></p>
<p>Cephalosporin-class:</p>
<p>-Frequency not reported: False-positive test for urinary glucose<sup>[Ref]</sup></p><h3>Respiratory</h3><p><b>Uncommon</b> (0.1% to 1%): Dyspnea, nasal congestion</p>
<p><b>Postmarketing reports</b>: Stridor<sup>[Ref]</sup></p><h3>Genitourinary</h3><p><b>Uncommon</b> (0.1% to 1%): Dysuria, vaginitis</p>
<p><b>Frequency not reported</b>: Hematuria<sup>[Ref]</sup></p><h3>Psychiatric</h3><p><b>Frequency not reported</b>: Agitation, irritability, insomnia</p>
<p><b>Postmarketing reports</b>: Psychosis<sup>[Ref]</sup></p><h3>Hypersensitivity</h3><p><b>Postmarketing reports</b>: Serum sickness-like reactions</p>
<p></p>
<p>Cephalosporin-class:</p>
<p>-Frequency not reported: Allergic reactions, anaphylaxis<sup>[Ref]</sup></p><div class="referenceList"><h4 id="refs">References</h4><p id="ref_1">1. "Product Information. Cedax (ceftibuten)." Schering-Plough, Liberty Corner, NJ. </p><p id="ref_2">2. Aubier MA "Comparison of ceftibuten versus amoxicillin/clavulanate in the treatment of acute exacerbations of chronic bronchitis." Chemotherapy 43 (1997): 297-302</p><p id="ref_3">3. McAdoo MA, Rice K, Gordon GR, Sahn SA "Comparison of ceftibuten once daily and amoxicillin-clavulanate three times daily in the treatment of acute exacerbations of chronic bronchitis." Clin Ther 20 (1998): 88-100</p><p id="ref_4">4. Owens RC, Nightingale CH, Nicolau DP "Ceftibuten: an overview." Pharmacotherapy 17 (1997): 707-20</p><p id="ref_5">5. Sterkers O "Efficacy and tolerability of ceftibuten versus amoxicillin/clavulanate in the treatment of acute sinusitis." Chemotherapy 43 (1997): 352-7</p><p id="ref_6">6. Schatz BS, Karavokiros KT, Taeubel MA, Itokazu GS "Comparison of cefprozil, cefpodoxime proxetil, loracarbef, cefixime, and ceftibuten." Ann Pharmacother 30 (1996): 258-68</p><p id="ref_7">7. David RP "Ceftibuten: a new expanded-spectrum oral cephalsporin." Ann Pharmacother 31 (1997): 1022-33</p><p id="ref_8">8. "Ceftibuten--a new oral cephalosporin." Med Lett Drugs Ther 38 (1996): 23-4</p><p id="ref_9">9. Romano A, Mayorga C, Torres MJ, Artesani MC, Suau R, Sanchez F, Perez E, Venuti A, Blanca M "Immediate allergic reactions to cephalosporins: Cross-reactivity and selective responses." J Allerg Clin Immunol 106 (2000): 1177-83</p></div>
<div class="more-resources" id="moreResources">
<h2>More about ceftibuten</h2>
<ul class="more-resources-list more-resources-list-general">
<li>During Pregnancy or 
Breastfeeding</li>
<li>Dosage Information</li>
<li>Drug Interactions</li>
<li>3 Reviews</li>
<li>Drug class: third generation cephalosporins</li>
</ul>
<h3>Consumer resources</h3>
<ul class="more-resources-list more-resources-list-consumer">
<li>Advanced Reading</li>
</ul>
<dl class="more-resources-other-brands more-resources-other-brands-consumer"><dt>Other brands</dt><dd>Cedax</dd></dl>
<h3>Professional resources</h3>
<ul class="more-resources-list more-resources-list-professional">
<li>Prescribing Information</li>
<li data-more-config-id="list-data-resources-professional">... +2 more</li>
</ul>
<h3>Related treatment guides</h3>
<ul class="more-resources-list more-resources-list-conditions">
<li>Bladder Infection</li>
<li>Bronchitis</li>
<li>Otitis Media</li>
<li>Pneumonia</li>
<li data-more-config-id="list-data-resources-conditions">... +3 more</li>
</ul>
</div>
<h2>Further information</h2><p class="ddc-disclaimer">Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.</p>
<p>Some side effects may not be reported. You may report them to the FDA.</p>
<p class="ddc-disclaimer-link">Medical Disclaimer</p>
<script>
function showRefs(refs) {
	if (!document.querySelectorAll) {
		return;
	}

	var referenceIds = refs ? refs.split(',') : [];
	var referenceTitle = referenceIds.length
		 ? "References relevant to chosen section <span class='ddc-text-size-small font-weight-normal'>(<a href='#refs' onclick='showRefs(\"\"); return false;'>Show all references</a>)</span>"
		 : "References";
	document.getElementById('refs').innerHTML = referenceTitle;

	// Show/hide reference items
	var referenceList = document.querySelectorAll('.referenceList p');
	referenceList.forEach(function(item) {
		var id = item.id.replace('ref_', '');
		if (!referenceIds.length || referenceIds.includes(id)) {
			item.style.display = 'block';
		}
		else {
			item.style.display = 'none';
		}
	});
}
</script>
</p><h2 class="ddc-anchor-offset" id="professional">For Healthcare Professionals</h2><p><i>Applies to ceftibuten: oral capsule, oral powder for reconstitution</i></p><h3>General</h3><p>This drug was generally well tolerated.  In clinical trials, 2% of patients discontinued medication due to adverse events, primarily diarrhea, nausea, or vomiting, and 0.3% discontinued due to rash or pruritus.<sup>[Ref]</sup></p><h3>Gastrointestinal</h3><p>The onset of pseudomembranous colitis symptoms has been reported during or after antibacterial therapy.<sup>[Ref]</sup></p><p><b>Common</b> (1% to 10%): Nausea, diarrhea, dyspepsia, abdominal pain, vomiting</p><p><b>Uncommon</b> (0.1% to 1%): Constipation, dry mouth, eructation, flatulence, loose stools</p><p><b>Postmarketing reports</b>: Melena</p><p></p><p>Cephalosporin-class:</p><p>-Frequency not reported: Pseudomembranous colitis<sup>[Ref]</sup></p><h3>Nervous system</h3><p>Some cephalosporins have been associated with seizures, especially in patients with renal dysfunction whose dose was not reduced.<sup>[Ref]</sup></p><p><b>Common</b> (1% to 10%): Headache, dizziness</p><p><b>Uncommon</b> (0.1% to 1%): Somnolence, taste perversion, paresthesia</p><p><b>Frequency not reported</b>: Hyperkinesia</p><p><b>Postmarketing reports</b>: Aphasia</p><p></p><p>Cephalosporin-class:</p><p>-Frequency not reported: Seizures<sup>[Ref]</sup></p><h3>Hepatic</h3><p><b>Common</b> (1% to 10%): Increased ALT, increased bilirubin</p><p><b>Uncommon</b> (0.1% to 1%): Increased AST</p><p><b>Postmarketing reports</b>: Jaundice</p><p></p><p>Cephalosporin-class:</p><p>-Frequency not reported: Hepatic cholestasis<sup>[Ref]</sup></p><h3>Hematologic</h3><p><b>Common</b> (1% to 10%): Increased eosinophils, decreased hemoglobin</p><p><b>Uncommon</b> (0.1% to 1%): Increased platelets, decreased platelets, decreased leukocytes</p><p></p><p>Cephalosporin-class:</p><p>-Frequency not reported: Aplastic anemia, hemolytic anemia, prolonged prothrombin time, hemorrhage, neutropenia, pancytopenia, agranulocytosis<sup>[Ref]</sup></p><h3>Renal</h3><p><b>Common</b> (1% to 10%): Increased BUN</p><p><b>Uncommon</b> (0.1% to 1%): Increased creatinine</p><p></p><p>Cephalosporin-class:</p><p>-Frequency not reported: Renal dysfunction, toxic nephropathy<sup>[Ref]</sup></p><h3>Dermatologic</h3><p><b>Uncommon</b> (0.1% to 1%): Pruritus, rash, urticaria</p><p><b>Frequency not reported</b>: Diaper dermatitis</p><p><b>Postmarketing reports</b>: Stevens-Johnson syndrome, toxic epidermal necrolysis</p><p></p><p>Cephalosporin-class:</p><p>-Frequency not reported: Stevens-Johnson syndrome, erythema multiforme<sup>[Ref]</sup></p><h3>Other</h3><p><b>Uncommon</b> (0.1% to 1%): Fatigue, moniliasis, increased alkaline phosphatase</p><p><b>Frequency not reported</b>: Fever, rigors, transient increases in lactate dehydrogenase</p><p></p><p>Cephalosporin-class:</p><p>-Frequency not reported: Drug fever<sup>[Ref]</sup></p><h3>Metabolic</h3><p><b>Uncommon</b> (0.1% to 1%): Anorexia</p><p><b>Frequency not reported</b>: Dehydration</p><p></p><p>Cephalosporin-class:</p><p>-Frequency not reported: False-positive test for urinary glucose<sup>[Ref]</sup></p><h3>Respiratory</h3><p><b>Uncommon</b> (0.1% to 1%): Dyspnea, nasal congestion</p><p><b>Postmarketing reports</b>: Stridor<sup>[Ref]</sup></p><h3>Genitourinary</h3><p><b>Uncommon</b> (0.1% to 1%): Dysuria, vaginitis</p><p><b>Frequency not reported</b>: Hematuria<sup>[Ref]</sup></p><h3>Psychiatric</h3><p><b>Frequency not reported</b>: Agitation, irritability, insomnia</p><p><b>Postmarketing reports</b>: Psychosis<sup>[Ref]</sup></p><h3>Hypersensitivity</h3><p><b>Postmarketing reports</b>: Serum sickness-like reactions</p><p></p><p>Cephalosporin-class:</p><p>-Frequency not reported: Allergic reactions, anaphylaxis<sup>[Ref]</sup></p><p id="ref_1">1. "Product Information. Cedax (ceftibuten)." Schering-Plough, Liberty Corner, NJ. </p><p id="ref_2">2. Aubier MA "Comparison of ceftibuten versus amoxicillin/clavulanate in the treatment of acute exacerbations of chronic bronchitis." Chemotherapy 43 (1997): 297-302</p><p id="ref_3">3. McAdoo MA, Rice K, Gordon GR, Sahn SA "Comparison of ceftibuten once daily and amoxicillin-clavulanate three times daily in the treatment of acute exacerbations of chronic bronchitis." Clin Ther 20 (1998): 88-100</p><p id="ref_4">4. Owens RC, Nightingale CH, Nicolau DP "Ceftibuten: an overview." Pharmacotherapy 17 (1997): 707-20</p><p id="ref_5">5. Sterkers O "Efficacy and tolerability of ceftibuten versus amoxicillin/clavulanate in the treatment of acute sinusitis." Chemotherapy 43 (1997): 352-7</p><p id="ref_6">6. Schatz BS, Karavokiros KT, Taeubel MA, Itokazu GS "Comparison of cefprozil, cefpodoxime proxetil, loracarbef, cefixime, and ceftibuten." Ann Pharmacother 30 (1996): 258-68</p><p id="ref_7">7. David RP "Ceftibuten: a new expanded-spectrum oral cephalsporin." Ann Pharmacother 31 (1997): 1022-33</p><p id="ref_8">8. "Ceftibuten--a new oral cephalosporin." Med Lett Drugs Ther 38 (1996): 23-4</p><p id="ref_9">9. Romano A, Mayorga C, Torres MJ, Artesani MC, Suau R, Sanchez F, Perez E, Venuti A, Blanca M "Immediate allergic reactions to cephalosporins: Cross-reactivity and selective responses." J Allerg Clin Immunol 106 (2000): 1177-83</p><h2>More about ceftibuten</h2><ul class="more-resources-list more-resources-list-general">
<li>During Pregnancy or 
Breastfeeding</li>
<li>Dosage Information</li>
<li>Drug Interactions</li>
<li>3 Reviews</li>
<li>Drug class: third generation cephalosporins</li>
</ul><h3>Consumer resources</h3><ul class="more-resources-list more-resources-list-consumer">
<li>Advanced Reading</li>
</ul><h3>Professional resources</h3><ul class="more-resources-list more-resources-list-professional">
<li>Prescribing Information</li>
<li data-more-config-id="list-data-resources-professional">... +2 more</li>
</ul><h3>Related treatment guides</h3><ul class="more-resources-list more-resources-list-conditions">
<li>Bladder Infection</li>
<li>Bronchitis</li>
<li>Otitis Media</li>
<li>Pneumonia</li>
<li data-more-config-id="list-data-resources-conditions">... +3 more</li>
</ul><h2>Further information</h2><p class="ddc-disclaimer">Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.</p><p>Some side effects may not be reported. You may report them to the FDA.</p><p class="ddc-disclaimer-link">Medical Disclaimer</p>